Showing 6,074 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment guidelines

HIV/AIDS Guidelines App available for iOS and Android Devices

Editor's pick
U.S. Food & Drug Administration (FDA)
24 January 2016
New & experimental HIV treatments

IV and Injectable HIV Treatments Are Much Discussed -- But Won't Be Here Anytime Soon

Editor's pick
TheBody Pro
21 January 2016
Side effects

D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

News
21 January 2016
TB treatment

NICE publishes new guideline to better tackle tuberculosis

Editor's pick
NICE press release
15 January 2016
PrEP science

Two cases of PrEP failure on solo tenofovir pose significant research questions

News
14 January 2016
Side effects

Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Editor's pick
Poz
14 January 2016
Bad science & bogus treatments

I Watched Charlie Sheen on The Dr. Oz Show So You Don't Have To

Editor's pick
Poz
14 January 2016
New & experimental HIV treatments

ABIVAX announces positive top-line clinical Phase IIa data for novel HIV drug-candidate ABX464

Editor's pick
Medical News Today
13 January 2016
PrEP

Short- or Medium-Term PrEP Is Safer Than Aspirin

Editor's pick
AIDSMeds
13 January 2016
Ageing & HIV

Middle-aged people living with HIV have an increased risk of frailty

News
13 January 2016
New & experimental HIV treatments

Janssen, ViiV Healthcare Formalize Injectable Rilpivirine + Cabotegravir Phase 3 as HIV Treatment

Editor's pick
Street Insider
8 January 2016
Viral load

Undetectable & Low-level HIV Viral Replication

Editor's pick
BETA blog
6 January 2016
Undetectable viral load & treatment as prevention

Young Men With Detectable Viral Loads More Likely to Engage in Risky Behavior

Editor's pick
HIVPlusMag
5 January 2016
People with limited treatment options

HIV salvage regimens can safely omit NRTIs, says US study

News
4 January 2016
New & experimental HIV treatments

HIV Antibody Infusion Safely Suppresses Virus in Infected People

Editor's pick
National Institute of Allergy and Infectious Diseases (NIAID)
24 December 2015
Drug interactions & pharmacokinetics

Many patients on new HCV medications at risk of drug-drug interactions

Editor's pick
Medscape (requires free registration)
23 December 2015
New & experimental HIV treatments

Scientists reveal new phase of HIV infection

Editor's pick
Science Daily
19 December 2015
Pharmaceutical industry

Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare

Editor's pick
Bristol-Myers Squibb press release
18 December 2015
New & experimental HIV treatments

Tenofovir alafenamide fumarate at what price? No more than $1000 a year above existing tenofovir formulation, says model

News
18 December 2015
Treatment simplification strategies

Two-drug ART with dolutegravir-lamivudine would be cost-effective and achieve substantial cash savings

News
17 December 2015
The search for a cure

Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies

Editor's pick
Sangamo Biosciences press release
14 December 2015
PrEP science

Drug resistance acquired during HIV PrEP rapidly disappears after medication is discontinued

News
14 December 2015
Changing treatment

Study: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options

Editor's pick
BETA blog
10 December 2015
PrEP

South African Medicines Agency approves PrEP

Editor's pick
South African MCC
8 December 2015